- Home
- EXK vs APLS Comparison
EXK vs APLS Comparison
Compare EXK & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXK | APLS |
|---|---|---|
| Founded | 1981 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | EXK | APLS |
|---|---|---|
| Price | $9.53 | $25.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 19 |
| Target Price | $11.69 | ★ $33.11 |
| AVG Volume (30 Days) | ★ 13.5M | 2.2M |
| Earning Date | 11-07-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | $337,137,000.00 | ★ $1,016,397,000.00 |
| Revenue This Year | $111.57 | $29.00 |
| Revenue Next Year | $64.09 | N/A |
| P/E Ratio | ★ N/A | $68.91 |
| Revenue Growth | ★ 49.22 | 42.11 |
| 52 Week Low | $2.95 | $16.10 |
| 52 Week High | $10.37 | $35.71 |
Technical Indicators
Market Signals| Indicator | EXK | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 62.94 | 69.22 |
| Support Level | $8.30 | $23.54 |
| Resistance Level | $9.13 | $24.45 |
| Average True Range (ATR) | 0.62 | 0.91 |
| MACD | 0.08 | 0.66 |
| Stochastic Oscillator | 84.78 | 99.01 |
Price Performance
Historical ComparisonAbout EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.